Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "stock-market-disclosure"

1 News Found

Wockhardt reports FY26 net profit of Rs 317 crore, Board approves fundraising plan
Biopharma | May 04, 2026

Wockhardt reports FY26 net profit of Rs 317 crore, Board approves fundraising plan

Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance